[{"from": "human", "value": "Please give me some details about this molecule. [C][C][O][C][=Branch1][C][=O][N][C@@H1][C][C][C@@H1][C@@H1][Branch1][Ring2][C][Ring1][=Branch1][C][C@@H1][C@H1][Branch2][Ring1][O][C@H1][Ring1][#Branch1][/C][=C][/C][=N][C][=C][Branch1][Branch1][C][=C][Ring1][=Branch1][C][=C][C][=Branch1][=Branch1][=C][C][=C][Ring1][=Branch1][F][C@H1][Branch1][#Branch1][O][C][Ring2][Ring1][Branch1][=O][C]"}, {"from": "gpt", "value": "The molecule is a tricyclic himbacine-derived selective inhibitor of protease activated receptor (PAR-1) indicated for reducing the incidence of thrombotic cardiovascular events in patients with a history of myocardial infarction (MI) or with peripheral arterial disease (PAD). By inhibiting PAR-1, a thrombin receptor expressed on platelets, vorapaxar prevents thrombin-related platelet aggregation."}]